Pioneer in behavioral pharmacology: a tribute to Joseph V. Brady.

Stephens (2008) wrote a tribute to Joseph V. Brady. The paper looks back at his career in behavioral pharmacology.

It shows how Brady used Estes-Skinner CER methods to study how drugs change behavior. The review covers decades of his work.

The tribute finds that Brady's CER approach is still the gold standard for drug-behavior studies. His method links basic lab work to real-world medication effects.

No new data are given. The paper simply honors Brady's lasting impact on the field.

Weeden et al. (2010) picks up Brady's baton. That paper tells BCBAs how to track behavior before and after med changes, just as Brady linked data to prescriptions.

Mace (1994) argued we need a three-step chain: animal model, human lab, then real setting. Brady lived that chain; the tribute shows his work is the proof of concept.

Lattal et al. (2022) sounds like it conflicts. They say animal trainers often skip lab tests, while Brady always started in the lab. The gap is context: Brady studied drugs, they study pet tricks. Both agree procedures must be tested, just in different arenas.

You can copy Brady's playbook. When a client starts a new med, run a simple CER probe: baseline rate, add med, watch rate change. Share the curve with the prescriber. One clear graph beats a page of notes.